Effectiveness of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke

Not yet recruitingOBSERVATIONAL
Enrollment

4,460

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Ginkgo Diterpene Lactone Meglumine

The specific administration protocol (including time of initiation, dosage, and treatment duration) should be strictly adhered to as per the physician's prescription and meticulously documented in the case report forms (CRFs).

Trial Locations (10)

130000

The First Hospital of Jilin University, Changchun

150000

Harbin Second Hospital, Harbin

The Fourth Affiliated Hospital of Harbin Medical University, Harbin

210000

Jiangsu Geriatric Hospital, Nanjing

Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing

221000

Xuzhou Hospital of Traditional Chinese Medicine, Xuzhou

272000

Affiliated Hospital of Jining Medical University, Jining

450000

Henan Provincial People's Hospital, Zhengzhou

710000

Xian Changan District Hospital, Xian

730000

Gansu Provincial People's Hospital, Lanzhou

All Listed Sponsors
lead

Ying Gao

OTHER

NCT06861426 - Effectiveness of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter